The 2014 Urology Times “State of the Specialty” survey shows that urologists remain frustrated with over-regulation by government, control of fees, meaningful use (meaningless use?), and a host of other rules that many argue add nothing to the quality of patient care.
This video demonstrates a unique, retractor-less approach to penoscrotal placement of the AMS 700 penile prosthesis (American Medical Systems)
The number of sexual partners a man has could be related to risk of being diagnosed with prostate cancer, Canadian researchers report.
Urologists know the International Classification of Diseases-10 (ICD-10) goes into effect Oct. 1, 2015. Whether they understand the transition’s impact and what they need to do to fully prepare are questionable.
Members of the Large Urology Group Practice Association will gather Nov. 6-8 in Chicago for the association’s annual meeting, and Urology Times will be delivering highlights of the meeting straight to your inbox.
In this interview, Eugene Y. Rhee, MD, MBA, discusses violent acts committed against urologists, the challenges of collecting and sharing data on potentially dangerous patients, and what some institutions are doing to protect their practices.
Research on the quality of bladder biopsy and bladder cancer survival point to problems of suboptimal biopsies and incorrect tumor staging, researchers say.
Inflammation may be the missing link between vitamin D and prostate cancer, new study findings from the University of Colorado Cancer Center in Denver suggest.
A study presented at the American Society for Reproductive Medicine annual meeting in Honolulu suggests a possible link between the recession of 2007-2009 and increasing vasectomy rates in the United States.
Papers examining the effects of diet and substance use on male fertility presented at the recently concluded American Society for Reproductive Medicine annual meeting in Honolulu may appear to provide conflicting findings, but an expert in andrology says the observational studies don’t tell the complete story.
As health care payment policy is changing at a rapid pace, many have found that partnership with the government is the best way to affect overall payment policy.
Urologists across the country describe treatment options for large kidney and ureteral stones.
In this article, Robert A. Dowling, MD, reviews the challenges of implementing active surveillance in a practice as well as ways to surmount these obstacles.
If an estate owner, based on his current financial situation, is not willing or able to contribute an entire financial asset during his lifetime, a split-interest, deferred gift is something to consider.
In separate actions, the FDA allowed the marketing of a urinary prosthesis for women and approved a supplemental new drug application for a lymphatic mapping agent.
Victor W. Nitti, MD, has been appointed by the AUA Board of Directors as the new Chair of the AUA Office of Education.
Palmetto GBA, a Medicare Administrative Contractor that assesses molecular diagnostic technologies, has issued a draft local coverage determination for the Prolaris prostate cancer test, Myriad Genetics, Inc. announced.
Robot-assisted radical prostatectomy is associated with a lower rate of blood transfusion and shorter length of stay compared to open surgery. However, the total first-year reimbursement is higher for RARP and there is no difference between the two procedures in the rate of postoperative complications or use of additional cancer treatment, according to an analysis of contemporary data from the Surveillance, Epidemiology, and End Results Medicare-linked database.
A new checklist-based assessment tool could prove to be useful for surgeons learning robot-assisted radical prostatectomy.
The application of dehydrated human amniotic membrane as a therapeutic patch covering the neurovascular bundle may have profound effects on the early recovery of erectile function in men undergoing nerve-sparing, robot-assisted laparoscopic radical prostatectomy, a retrospective study suggests.
An international team of surgeons from the U.S. and India continues to explore the potential of robotic kidney transplantation with regional hypothermia. The results of an IDEAL (Idea, Development, Exploration, Assessment, Long-term) phase IIb trial of the procedure support the promise seen in preceding trials.
It is with great excitement that we unveil our network-wide redesign. Please read further to learn more about a few of our new features, and browse around to explore the new site!
Abiraterone acetate (ZYTIGA) as therapy for chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC) improved overall survival by a statistically significant 19% compared with placebo in the final analysis of the phase III COU-AA-302 clinical trial.
Have you ever “Googled” yourself? If you haven't, try it. The results may surprise you. Simply type your name into Google or another search engine, hit search, and see what pops up. Not all of it is pretty.
The time is right for urologists to become familiar with all aspects of the use and delivery of these drugs.
A prostate cancer diagnostic test may have benefits beyond predicting tumor aggressiveness, a study presented at the European Society for Medical Oncology Congress showed.
New study data confirm the ability of the ConfirmMDx genes to identify prostate cancer aggressiveness in diagnostic biopsies, researchers reported.
The effort to draw attention to the importance of prostate cancer detection was given a big boost in September when conservative Sen. Jeff Sessions (R-AR) and liberal Sen. Barbara Boxer (D-CA) joined together to sponsor legislation to create the National Prostate Cancer Council.
Not all men's health centers are the same, but they do have several qualities in common.
Men’s health clinics are becoming a place where men can come in and get all or most of their health care needs met in one visit. These clinics, the subject of a recent article in Urology Times, differ in design and layout but are the same in their focus on providing comprehensive health care for men. This slideshow offers a look at the Center for Reconstructive Urology and Men’s Health, University of Utah, Salt Lake City